Form 4: Lemaitre Vascular Director Bridget A. Ross Reports Acquisition of Dividend Equivalent Rights
SEC Form 4 Filing
Director Bridget A. Ross reports the acquisition of dividend equivalent rights related to restricted stock units and performance share units.
Summary
- On March 28, 2024, Bridget A. Ross, a director of Lemaitre Vascular Inc. (LMAT), acquired dividend equivalent rights related to previously granted restricted stock units (RSUs) and performance share units (PSUs).
- These rights are economically equivalent to shares of LMAT common stock and vest proportionately with the underlying awards.
- The acquisitions include 0.476 rights related to RSUs granted on December 11, 2021, 0.9644 rights related to RSUs granted on December 12, 2022, 0.9644 rights related to PSUs granted on December 12, 2022, and 1.2345 rights related to RSUs granted on December 8, 2023.
- Following these transactions, Ross directly owns 6.9143, 5.9511, 4.9624 and 1.2345 dividend equivalent rights respectively.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding director compensation, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to director compensation and equity awards, common in publicly traded companies.
Stakeholder Impact
- The acquisition of dividend equivalent rights has a minor impact on shareholders as it relates to director compensation.
Key Dates
| Date | Description |
|---|---|
| 12/11/2021 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award grant related to dividend equivalent rights. |
| 03/28/2024 | Date of transaction: Acquisition of dividend equivalent rights. |
| 04/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.